Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05123482
What this trial is testing

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Who this might be right for
Breast CancerBiliary Tract CarcinomaOvarian Cancer+2 more
AstraZeneca 460
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Post-approval studies (Phase 4)Ended earlyNCT01887041
What this trial is testing

Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer

Who this might be right for
Local Tumor SpreadAdvanced CancerMetastasized+2 more
Universitätsklinikum Hamburg-Eppendorf 24
Testing effectiveness (Phase 2)Study completedNCT00948935
What this trial is testing

Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma

Who this might be right for
Biliary CancerCholangiocarcinoma
Abramson Cancer Center at Penn Medicine 35
Large-scale testing (Phase 3)Study completedNCT04003636
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 1,069
Testing effectiveness (Phase 2)Study completedNCT03830606
What this trial is testing

The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma

Who this might be right for
Biliary Tract Cancer
Aiping Zhou 54
Testing effectiveness (Phase 2)UnknownNCT01494363
What this trial is testing

Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Soon Chun Hyang University 53
Testing effectiveness (Phase 2)Ended earlyNCT00023946
What this trial is testing

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more
National Cancer Institute (NCI) 50
Not applicableStudy completedNCT01401894
What this trial is testing

Perception Prognosis, Goals of Treatment, and Communication

Who this might be right for
Gastric CancerEsophageal CancerPancreatic Cancer+2 more
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07099794
What this trial is testing

A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen

Who this might be right for
Biliary Tract Cancer (BTC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 90
Not applicableNot Yet RecruitingNCT07169916
What this trial is testing

Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Fudan University 210
Testing effectiveness (Phase 2)Looking for participantsNCT06708663
What this trial is testing

HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours

Who this might be right for
Biliary Tract CancerMelanoma
Hangzhou Hanx Biopharmaceuticals, Ltd. 124
Testing effectiveness (Phase 2)UnknownNCT05823987
What this trial is testing

Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)

Who this might be right for
Advanced Biliary Tract Cancer
Fudan University 25
Early research (Phase 1)Looking for participantsNCT04999761
What this trial is testing

AB122 Platform Study

Who this might be right for
Advanced or Metastatic Solid TumorPancreatic Ductal AdenocarcinomaColorectal Cancer+6 more
Taiho Pharmaceutical Co., Ltd. 917
Testing effectiveness (Phase 2)Study completedNCT01153750
What this trial is testing

Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

Who this might be right for
Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct
University Hospital Dresden 44
Large-scale testing (Phase 3)Looking for participantsNCT07229625
What this trial is testing

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

Who this might be right for
Advanced Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 604
Testing effectiveness (Phase 2)UnknownNCT03702491
What this trial is testing

Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

Who this might be right for
Gallbladder Carcinoma
Eastern Hepatobiliary Surgery Hospital 138
Early research (Phase 1)Ended earlyNCT01282333
What this trial is testing

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+11 more
National Cancer Institute (NCI) 44
Next Page